Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

GHRP-6 research

6 articles to explore, with links to 6 original sources.

About GHRP-6

GHRP-6 is a synthetic hexapeptide used in growth hormone secretagogue receptor research.

Understand the science

  • How a 2026 experiment studied cardiac remodeling after a blocked artery

    GHRP-6, short for growth hormone–releasing peptide 6, is a six-residue peptide that activates the ghrelin receptor. In March 2026 researchers reported what happened when they studied GHRP-6 after a coronary artery was permanently blocked in rats.

    2 sources (2021, 2026)

  • How a six-residue peptide can fit the ghrelin receptor

    GHRP-6 is a synthetic six-residue growth hormone–releasing peptide that activates the ghrelin receptor. How can it activate the same receptor as ghrelin, a longer natural hormone with a different chemical structure?

    1 source (2021)

Explore study findings

  • Why preventing a raised scar differs from reversing one

    GHRP-6 is a synthetic six-residue peptide that activates the ghrelin receptor and promotes growth hormone release in experimental settings. An animal study asked whether exposure to GHRP-6 changed the development of a raised scar or the appearance of an already mature scar.

    2 sources (2018, 2021)

  • Why a human blood study reported two half-lives

    GHRP-6 is a six-residue synthetic growth hormone–releasing peptide. In a small human study, researchers asked which mathematical model best described the decline of GHRP-6 itself in blood. No recent primary human study directly repeating this time-course experiment was identified.

    1 source (2012)

Check methods and identity

  • What a rat stroke experiment measured in tissue near the injury

    GHRP-6 is a six-residue synthetic growth hormone secretagogue and ghrelin-receptor agonist. A 2026 animal study examined the proteins that changed after GHRP-6 and epidermal growth factor (EGF) were given together in a stroke model.

    3 sources (2021, 2026)

Interpret the evidence

  • What the 2026 COURAGE-2 stroke trial found about a specific combination

    Growth hormone–releasing peptide 6, or GHRP-6, is a synthetic six-residue peptide that activates the ghrelin receptor and can stimulate growth hormone release. In 2026, a clinical trial reported whether a combination containing GHRP-6 improved disability after acute ischemic stroke.

    2 sources (2021, 2026)

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.